Moderna (MRNA) stock contnues to tumble as J.P. Morgan and Jefferies downgrade the biotech following updates at the company's ...

Moderna's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, ...

By investing heavily on EV R&D, India can further localise production to create more jobs, tap export markets to gain global ...

Moderna MRNA announced a strategic overhaul and new financial guidance at its R&D day on Sept. 12, and we’ve lowered our fair value estimate to $141 per share from $227. We’ve repeatedly ...

Focuses on ten product approvals through 2027 Expects to submit next-generation COVID vaccine for approval in 2024 Expects to submit flu/COVID combination vaccine for approval in 2024 Announces ...

Moderna Inc.’s shares (NASDAQ:MRNA) sank 19% to a $64.11 low in early trading Sept. 12 as investors learned during the annual ...

Moderna announced a strategic overhaul and new financial guidance at its R&D day on Sept. 12, and we’ve lowered our fair value estimate to $141 per share from $227. We’ve repeatedly pointed to ...

Drug maker Moderna, Inc. (MRNA), at its annual R&D Day event on Thursday, presented its outlook for fiscal 2025 and beyond, as well ...

Following an over 12% decline in the previous session in reaction to updates at the company’s R&D Day event, Moderna (NASDAQ:MRNA) shares continued to tumble in the pre-market on Friday as J.P ...

Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on September 13. Analyst Mani ...

The prestigious KNS Annual Award will be presented to Jerome Moras, Lucy Mascarenhas, and Martin R. D'Souza during the KNS Annual Day celebrations, scheduled for Sunday, September 22, at 5:30 PM at ...